Company Overview
Magnentum Inc. is a Joint Venture of ADI Group and Ken Robinson in the domain of Clinical Trial Regulatory Services. Driven by the innovation, passion and experience of industry experts, Magnentum offers the pharmaceutical industry expert solutions for drug development needs – from study design through the final submission. Magnentum has extensive experience and is well acquainted with multiple approaches to documenting clinical trials in over 100 regulatory submissions including NDAs, MAAs, marketing applications in Asia, background packages, and a full range of other clinical documents required at various stages for regulatory submissions.
Our strength is our cross-functional team that ensures all these challenges are solved under one roof. Magnentum is co-founded by a 30+ years’ experience serial entrepreneur from the healthcare sector, and a 35+ years’ a serial entrepreneur with 30+ years experience in the healthcare sector, and a 35+ years’ experience medical writing director turned entrepreneur with 30+ years experience in regulatory writing. Our expertise across the information and communication domains includes:
• Medical animation, clinical trial training and recruitment videos, explainer videos, scientific writing, posters and presentations;
• Regulatory/Scientific writing which includes IND, NDA, CSR, Study Design, Investigator Brochure, and relevant documents; and
• Mining of Research Paper to support your argument.